Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07125326 · ClinicalTrials.gov registry record · NA

How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding

A NA study of Urinary Retention and Urinary Tract Infection (Diagnosis), sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
564
Enrollment target
1
Study location

NCT07125326: Recruiting NA study of Urinary Retention and Urinary Tract Infection (Diagnosis), sponsored by University of Pittsburgh.

NCT07125326 is a NA study of Urinary Retention and Urinary Tract Infection (Diagnosis) that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 564 participants, above the 89-participant average among 11 other Urinary Retention trials with a reported enrollment target (534% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07125326, a NA study of Urinary Retention and Urinary Tract Infection (Diagnosis), is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
564 participants
Enrollment target
1
Study location

Study Summary

At least ten percent of patients have postpartum urinary retention or difficulty urinating after birth, which can cause incontinence and other urinary problems long-term. After getting an epidural placed, patients should be numb in their pelvic region. This numbness makes it difficult to feel the need to urinate, so patients need a urinary catheter placed to empty the bladder. Some patients have one catheter placed throughout their labor and others have a catheter placed to empty the bladder then removed every few hours. The investigators are studying whether placing a catheter once or catheterizing multiple times affects the rate of postpartum urinary problems and infection.

Primary Outcome

Urinary retention defined as overt inability to void at six hours after last bladder emptying postpartum or symptomatic incomplete emptying, or covert retention of \>150cc urine in the bladder after voiding Collecting number of participants who experience this

Interventions

  • PROCEDURE Intermittent catheterization
  • PROCEDURE Continuous catheterization

Study Locations (1)

Pennsylvania

  • UPMC Magee-Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 564 participants
Start Date 2025-12-09
Est. Completion 2027-08
Phase NA
University of Pittsburgh

1,238 total trials

What NCT07125326 shows while recruiting

NCT07125326 is an interventional study that assigns participants to a tested intervention. The registered 564 participants enrollment target is mid-sized for trials with a published cap, above the 89-participant average among 11 other Urinary Retention trials with a reported enrollment target (534% higher).

The record links to 5 conditions, with Urinary Retention appearing as the primary indexed condition, and to 2 interventions - of which Intermittent catheterization is the first listed.

NCT07125326 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07125326 about?

NCT07125326 is a clinical study titled "How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding". At least ten percent of patients have postpartum urinary retention or difficulty urinating after birth, which can cause incontinence and other urinary problems long-term. After getting an epidural placed, patients should be numb in their pelvic region. This numbness makes it difficult to feel the ne...

What is the current status of trial NCT07125326?

This trial is currently recruiting. It is a NA study. The enrollment target is 564 participants. The study started on 2025-12-09. Estimated completion is 2027-08.

What conditions does trial NCT07125326 study?

This clinical trial studies the following conditions: Urinary Retention, Urinary Tract Infection (Diagnosis), Postpartum Care, Voiding Dysfunction, Postpartum Acute Urinary Retention.

What interventions are being tested in trial NCT07125326?

The interventions under investigation include: Intermittent catheterization (PROCEDURE), Continuous catheterization (PROCEDURE).

Who is sponsoring clinical trial NCT07125326?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07125326 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Retention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07125326's enrollment target sits among peer trials

564 1st of 11 higher than 11 of 11 other Urinary Retention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Urinary Retention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06146725 · 564 participants

    The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

  • NCT06188520 · 564 participants · Phase 1

    A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

  • NCT06628453 · 564 participants · NA

    CGM for Management of Type 2 Diabetes in Pregnancy

  • NCT07007065 · 561 participants · Phase 3

    Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07125326, the US trial registry maintained by the National Library of Medicine. NCT07125326 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.